Cystic fibrosis-related diabetes testing in Castelfranco Emilia
Find health labs to test for Cystic fibrosis-related diabetes in Castelfranco Emilia and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by Farmacia Beata Vergine della Salute
Corso Canalchiaro, 127, 41121 Modena MO, Italia
7.1 km
Hemoglobin Test by Farmacia Pian di Macina
Via Ottavio Garganelli, 13, 40065 Pianoro BO, Italia
20.4 km
Diabetes Test by Gemini Srl - Poliambulatorio a Parma
Piazza Sisto Rosa Badalocchio, 3, 43126 Parma PR, Italia
38.3 km
Diabetes Test by GmLab sede di Locorotondo (BA)
Viale Giosuè Carducci, 3, 44034 Copparo FE, Italia
43.3 km
Hemoglobin Test by Synlab
Piazza Dante Alighieri, 63, 50032 Borgo San Lorenzo FI, Italia
47.3 km
Hemoglobin Test by Farmacia Etrusca
Via Pistoiese, 174, 59100 Prato PO, Italia
49.5 km
Hemoglobin Test by Farmacia Picconi
Via Provinciale Montalbano, 371, 51034 Serravalle Pistoiese PT, Italia
49 km
Diabetes Test by Centro analisi cliniche Madonie
Via Antonio Gramsci, 39, 50019 Sesto Fiorentino FI, Italia
53.3 km
Diabetes Test by Synlab
Via Sorte, 48, 37047 San Bonifacio VR, Italia
56.3 km
Hemoglobin Test by Synlab
Piazza della Stazione, 2, 50123 Firenze FI, Italia
58 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
